Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |